Biotech "2020 2: This Time With Feeling" Mongoose

Genome engineerin' expert;
Small carnivorous mammal;
Punches =/= pulled

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

Ahahahaahhahahahahahahahah

[Max Bayer @maxonwifi]

An @endpts exclusive: @RepMoolenaar and @RepDebDingell will unveil a bill later today that adds biotech to the outbound investment screening list via the COINS Act. In a statement, Moolenaar called recent Pfizer and BMS pacts "dangerous deals." https://t.co/e6Ph0wRZqG

[Goose Data (wa/wa) @GooseData]

Remember, big pharma should be bag holders for US VCs, not Chinese ones!

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

@fulop_dan There isn't one now. There was going to be a resolution eventually, as Powell was going to pull off the nearly impossible with a soft landing, and the money would have come back.

But orange man dumb.

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

It's really cool that all the usual biotech grifter suspects are insanely delusional now.

"To stop China, we must become Russia"

"Biotech isn't a ZIRP! IT'S NOT!"

"US patients have to pay high prices; otherwise the companies that aren't hiring anyone won't hire anyone!"

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

Hoover Institute is all one really needs to know about him.

[Murtaza Hussain @MazMHussain]

This person is apparently a highly respected historian at Stanford.

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

What the biotech brosephs fail to understand is that there is functionally only one way to "save" US biotech in the manner they want: interest rates go to zero again. Warsh will absolutely try to do this for unrelated reasons and it will straightup destroy the US economy

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

@lpachter People can work on whatever they want, but actively choosing to work on the most "counting angels on the head of pin" stuff I've seen in recent times while being fully aware of the current political climate is certainly a choice Sean made.

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

It is...difficult to make the case that someone shouldn't lose funding now for doing essentially no work because they did important work years and years ago.

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

@fulop_dan Eddy

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

@bornspectator42 I think another two years and only the biggest BSDs will be allowed to publish atlas-type papers in actual Cell. Everyone else will be relegated to Cell Systems.

Not sure what Nature and Science will do.

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

That's because biotech in the US is a ZIRP

[owl @owl_posting]

bleak that the primary people who are worried about chinese biotech are people who actually work in the field, and everyone telling them to chill out are either VC’s or journalists

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

@bornspectator42 @Nale Actually, I think this is "European signs kid up for travel team without bothering to understand what it means in the US". If this was about having "zero chill in regular youth sports", it would be about multiple parents getting into physical altercations with coach/parents.

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

@billytcl Right, but then getting a kingmaker fellowship becomes something that a trainee can reasonably aspire to and that goes against the mythologizing of the BSDs, so you need an even more exclusive award for even earlier for high risk high reward like "making your lab drink with you"

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

If the DP5 was actually about being aspirational towards science instead of what it's actually about, there wouldn't have been a limit of 2 applications per institution per call

[Emma J Chory @chorye]

This is a horrifically dumb take even for @BiotechMongoose.

Even when the odds are long, and not in your favor, these awards matter. They give young scientists ambitious, almost impossible goals to aim for. Their impact is not only on the few people who win, but on everyone who stretches toward that standard, pushing science forward. When these opportunities disappear, so do the aspirations they inspire.

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

@WalentekLab You're in Germany. I don't think you have the same insights into the NIH system as someone in the US, just like I don't comment on your European funding mechanisms and institutes.

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

@chorye These awards are first and foremost about reinforcing the status quo of the BSDs, because perhaps the K99s became a little bit too fair to get

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

@chorye Bzzt wrongo as usual.

They reinforce the idea that you only matter in biosci if you work for the "right" people, if you're in the "right" place, that only being in certain labs offers a path to running a lab

Maybe you'd have an argument if this was about Hanna Gray, but it isnt

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

For those of you early in your careers or those of you that couldn't grasp how to play nice in a department that had gotten kinda sick of who you're associated with, "high-risk, high-reward" is NIH-speak for "only big names, BSDs and the well-connected need apply"

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

@neal_amin Also, Pioneer awards for the past 5 years have also been low risk, low reward despite *gasp* the description saying high risk, high reward!

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

Counterpoint: it, like virtually all the early-independence awards, is biased toward the well-connected and the exceptionally lucky, and more importantly, the people it goes to weren't going to leave biosci because they were already virtually all anointed.

[Emma J Chory @chorye]

This award is one of the only paths that gives a tiny number of exceptional PhD or clinical trainees the funding to launch their own research groups directly, rather than spending many years in a postdoc first. It lets them pursue their best ideas while they still have the most momentum. The people who win it are absolute superstars, and programs like this are one of the clearest ways we keep extraordinary talent in science.

[Biotech "2020 2: This Time With Feeling" Mongoose @BiotechMongoose]

@neal_amin It absolutely doesn't mean the Director's Office POs followed that. And from the awards given, virtually none of the work was high risk, maybe some were high reward but not many.

But go on, keep believing everything NIH puts in the non-rules section of a document.